ARCHIVES

Group Opposes Bill To Allow Drug Sales After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 20 | May 26, 2006

Download PDF Visit The Full Archive

Related Articles

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986